Cancer Research: Coley's Toxins
STEP ONE
Be informed. Read information below.
STEP TWO
Schedule consultation with R. Douglas Wichman, MD.
STEP THREE
Submit "New Patient Form", current labwork, & imaging results prior to consultation.
STEP FOUR
Establish if you are a candidate for this therapy
in accordance with the Georgia
"Access to Medical Treatment Act".
Coley Toxins is a form of immunotherapy using bacterial cultures that may improve the body’s immune system and prevent cancer. Studies going back as the 1700’s show that this treatment had reduced the malignancy of cancers. The active component in Coley’s Toxins is TNF alpha or Tumor necrosis factor alpha which was isolated in the 1970’s. TNF alpha is as a cytokine, a signaling molecule that alert cells to sites of inflammation, infection and trauma.
According to the British Journal of Medicine:
“A wide variety of evidence has pointed to a critical role of TNF-α in tumour proliferation, migration, invasion and angiogenesis. The function of TNF-α as a key regulator of the tumour microenvironment is well recognized. We will emphasize the contribution of TNF-α and the nuclear factor-κB pathway on tumour cell invasion and metastasis. Understanding the mechanisms underlying inflammation-mediated metastasis will reveal new therapeutic targets for cancer prevention and treatment.”
Wu, Y., and B P Zhou. “TNF-α/NF-κB/Snail Pathway in Cancer Cell Migration and Invasion.” Nature.com. Nature Publishing Group
Sources and Research:
Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective.
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility